PATRICIA BUSSMANN: Open Payments
NPI 1730362906 · BOYERTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 38 payments from 19 companies in 2025. Trend: 2023 $485 · 2024 $737 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $192 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Amgen Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABBVIE INC. | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Insulet Corporation | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
Products named: Ozempic, JARDIANCE, XIFAXAN, Rybelsus, Wegovy, OTEZLA, MOUNJARO, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
